ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Precision Cancer Tests Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-29I5820
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global and United States Precision Cancer Tests Market Report Forecast 2022 2028
BUY CHAPTERS

Global Precision Cancer Tests Market Research Report 2025

Code: QYRE-Auto-29I5820
Report
September 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott
BD
Bio Rad
Cynvenio Biosystems
Foundation Medicine
Genomic Health
Illumina Inc
Myriad Genetics
Nanostring Technologies
Qiagen NV
Randox Laboratories
Roche
Philips
Thermo Fisher Scientific

Precision Cancer Tests Market

The global market for Precision Cancer Tests was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Precision cancer tests encompass imaging and in vitro diagnostic products and procedures that directly detect malignancies in patient samples or in the patients themselves.
North American market for Precision Cancer Tests is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Precision Cancer Tests is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Precision Cancer Tests in Cancer Research Centers is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Precision Cancer Tests include Abbott, BD, Bio-Rad, Cynvenio Biosystems, Foundation Medicine, Genomic Health, Illumina, Myriad Genetics, NanoString Technologies, QIAGEN, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Precision Cancer Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Cancer Tests.
The Precision Cancer Tests market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Precision Cancer Tests market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Precision Cancer Tests companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Precision Cancer Tests Market Report

Report Metric Details
Report Name Precision Cancer Tests Market
Segment by Type
  • Imaging
  • In Vitro Diagnostic
  • Others
Segment by Application
  • Cancer Research Centers
  • Cancer Hospital
  • Surgical Centers
  • Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott, BD, Bio-Rad, Cynvenio Biosystems, Foundation Medicine, Genomic Health, Illumina, Myriad Genetics, NanoString Technologies, QIAGEN, Randox Laboratories, Roche, Philips, Thermo Fisher Scientific
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Precision Cancer Tests company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Precision Cancer Tests Market report?

Ans: The main players in the Precision Cancer Tests Market are Abbott, BD, Bio-Rad, Cynvenio Biosystems, Foundation Medicine, Genomic Health, Illumina, Myriad Genetics, NanoString Technologies, QIAGEN, Randox Laboratories, Roche, Philips, Thermo Fisher Scientific

What are the Application segmentation covered in the Precision Cancer Tests Market report?

Ans: The Applications covered in the Precision Cancer Tests Market report are Cancer Research Centers, Cancer Hospital, Surgical Centers, Clinics, Others

What are the Type segmentation covered in the Precision Cancer Tests Market report?

Ans: The Types covered in the Precision Cancer Tests Market report are Imaging, In Vitro Diagnostic, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Precision Cancer Tests Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Imaging
1.2.3 In Vitro Diagnostic
1.2.4 Others
1.3 Market by Application
1.3.1 Global Precision Cancer Tests Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer Research Centers
1.3.3 Cancer Hospital
1.3.4 Surgical Centers
1.3.5 Clinics
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Precision Cancer Tests Market Perspective (2020-2031)
2.2 Global Precision Cancer Tests Growth Trends by Region
2.2.1 Global Precision Cancer Tests Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Precision Cancer Tests Historic Market Size by Region (2020-2025)
2.2.3 Precision Cancer Tests Forecasted Market Size by Region (2026-2031)
2.3 Precision Cancer Tests Market Dynamics
2.3.1 Precision Cancer Tests Industry Trends
2.3.2 Precision Cancer Tests Market Drivers
2.3.3 Precision Cancer Tests Market Challenges
2.3.4 Precision Cancer Tests Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Precision Cancer Tests Players by Revenue
3.1.1 Global Top Precision Cancer Tests Players by Revenue (2020-2025)
3.1.2 Global Precision Cancer Tests Revenue Market Share by Players (2020-2025)
3.2 Global Precision Cancer Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Precision Cancer Tests Revenue
3.4 Global Precision Cancer Tests Market Concentration Ratio
3.4.1 Global Precision Cancer Tests Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Precision Cancer Tests Revenue in 2024
3.5 Global Key Players of Precision Cancer Tests Head office and Area Served
3.6 Global Key Players of Precision Cancer Tests, Product and Application
3.7 Global Key Players of Precision Cancer Tests, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Precision Cancer Tests Breakdown Data by Type
4.1 Global Precision Cancer Tests Historic Market Size by Type (2020-2025)
4.2 Global Precision Cancer Tests Forecasted Market Size by Type (2026-2031)
5 Precision Cancer Tests Breakdown Data by Application
5.1 Global Precision Cancer Tests Historic Market Size by Application (2020-2025)
5.2 Global Precision Cancer Tests Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Precision Cancer Tests Market Size (2020-2031)
6.2 North America Precision Cancer Tests Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Precision Cancer Tests Market Size by Country (2020-2025)
6.4 North America Precision Cancer Tests Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Precision Cancer Tests Market Size (2020-2031)
7.2 Europe Precision Cancer Tests Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Precision Cancer Tests Market Size by Country (2020-2025)
7.4 Europe Precision Cancer Tests Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Precision Cancer Tests Market Size (2020-2031)
8.2 Asia-Pacific Precision Cancer Tests Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Precision Cancer Tests Market Size by Region (2020-2025)
8.4 Asia-Pacific Precision Cancer Tests Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Precision Cancer Tests Market Size (2020-2031)
9.2 Latin America Precision Cancer Tests Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Precision Cancer Tests Market Size by Country (2020-2025)
9.4 Latin America Precision Cancer Tests Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Precision Cancer Tests Market Size (2020-2031)
10.2 Middle East & Africa Precision Cancer Tests Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Precision Cancer Tests Market Size by Country (2020-2025)
10.4 Middle East & Africa Precision Cancer Tests Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Precision Cancer Tests Introduction
11.1.4 Abbott Revenue in Precision Cancer Tests Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 BD
11.2.1 BD Company Details
11.2.2 BD Business Overview
11.2.3 BD Precision Cancer Tests Introduction
11.2.4 BD Revenue in Precision Cancer Tests Business (2020-2025)
11.2.5 BD Recent Development
11.3 Bio-Rad
11.3.1 Bio-Rad Company Details
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad Precision Cancer Tests Introduction
11.3.4 Bio-Rad Revenue in Precision Cancer Tests Business (2020-2025)
11.3.5 Bio-Rad Recent Development
11.4 Cynvenio Biosystems
11.4.1 Cynvenio Biosystems Company Details
11.4.2 Cynvenio Biosystems Business Overview
11.4.3 Cynvenio Biosystems Precision Cancer Tests Introduction
11.4.4 Cynvenio Biosystems Revenue in Precision Cancer Tests Business (2020-2025)
11.4.5 Cynvenio Biosystems Recent Development
11.5 Foundation Medicine
11.5.1 Foundation Medicine Company Details
11.5.2 Foundation Medicine Business Overview
11.5.3 Foundation Medicine Precision Cancer Tests Introduction
11.5.4 Foundation Medicine Revenue in Precision Cancer Tests Business (2020-2025)
11.5.5 Foundation Medicine Recent Development
11.6 Genomic Health
11.6.1 Genomic Health Company Details
11.6.2 Genomic Health Business Overview
11.6.3 Genomic Health Precision Cancer Tests Introduction
11.6.4 Genomic Health Revenue in Precision Cancer Tests Business (2020-2025)
11.6.5 Genomic Health Recent Development
11.7 Illumina
11.7.1 Illumina Company Details
11.7.2 Illumina Business Overview
11.7.3 Illumina Precision Cancer Tests Introduction
11.7.4 Illumina Revenue in Precision Cancer Tests Business (2020-2025)
11.7.5 Illumina Recent Development
11.8 Myriad Genetics
11.8.1 Myriad Genetics Company Details
11.8.2 Myriad Genetics Business Overview
11.8.3 Myriad Genetics Precision Cancer Tests Introduction
11.8.4 Myriad Genetics Revenue in Precision Cancer Tests Business (2020-2025)
11.8.5 Myriad Genetics Recent Development
11.9 NanoString Technologies
11.9.1 NanoString Technologies Company Details
11.9.2 NanoString Technologies Business Overview
11.9.3 NanoString Technologies Precision Cancer Tests Introduction
11.9.4 NanoString Technologies Revenue in Precision Cancer Tests Business (2020-2025)
11.9.5 NanoString Technologies Recent Development
11.10 QIAGEN
11.10.1 QIAGEN Company Details
11.10.2 QIAGEN Business Overview
11.10.3 QIAGEN Precision Cancer Tests Introduction
11.10.4 QIAGEN Revenue in Precision Cancer Tests Business (2020-2025)
11.10.5 QIAGEN Recent Development
11.11 Randox Laboratories
11.11.1 Randox Laboratories Company Details
11.11.2 Randox Laboratories Business Overview
11.11.3 Randox Laboratories Precision Cancer Tests Introduction
11.11.4 Randox Laboratories Revenue in Precision Cancer Tests Business (2020-2025)
11.11.5 Randox Laboratories Recent Development
11.12 Roche
11.12.1 Roche Company Details
11.12.2 Roche Business Overview
11.12.3 Roche Precision Cancer Tests Introduction
11.12.4 Roche Revenue in Precision Cancer Tests Business (2020-2025)
11.12.5 Roche Recent Development
11.13 Philips
11.13.1 Philips Company Details
11.13.2 Philips Business Overview
11.13.3 Philips Precision Cancer Tests Introduction
11.13.4 Philips Revenue in Precision Cancer Tests Business (2020-2025)
11.13.5 Philips Recent Development
11.14 Thermo Fisher Scientific
11.14.1 Thermo Fisher Scientific Company Details
11.14.2 Thermo Fisher Scientific Business Overview
11.14.3 Thermo Fisher Scientific Precision Cancer Tests Introduction
11.14.4 Thermo Fisher Scientific Revenue in Precision Cancer Tests Business (2020-2025)
11.14.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Abbott
BD
Bio Rad
Cynvenio Biosystems
Foundation Medicine
Genomic Health
Illumina Inc
Myriad Genetics
Nanostring Technologies
Qiagen NV
Randox Laboratories
Roche
Philips
Thermo Fisher Scientific
List of Tables
 Table 1. Global Precision Cancer Tests Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Imaging
 Table 3. Key Players of In Vitro Diagnostic
 Table 4. Key Players of Others
 Table 5. Global Precision Cancer Tests Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Precision Cancer Tests Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Precision Cancer Tests Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Precision Cancer Tests Market Share by Region (2020-2025)
 Table 9. Global Precision Cancer Tests Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Precision Cancer Tests Market Share by Region (2026-2031)
 Table 11. Precision Cancer Tests Market Trends
 Table 12. Precision Cancer Tests Market Drivers
 Table 13. Precision Cancer Tests Market Challenges
 Table 14. Precision Cancer Tests Market Restraints
 Table 15. Global Precision Cancer Tests Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Precision Cancer Tests Market Share by Players (2020-2025)
 Table 17. Global Top Precision Cancer Tests Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Tests as of 2024)
 Table 18. Ranking of Global Top Precision Cancer Tests Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Precision Cancer Tests Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Precision Cancer Tests, Headquarters and Area Served
 Table 21. Global Key Players of Precision Cancer Tests, Product and Application
 Table 22. Global Key Players of Precision Cancer Tests, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Precision Cancer Tests Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Precision Cancer Tests Revenue Market Share by Type (2020-2025)
 Table 26. Global Precision Cancer Tests Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Precision Cancer Tests Revenue Market Share by Type (2026-2031)
 Table 28. Global Precision Cancer Tests Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Precision Cancer Tests Revenue Market Share by Application (2020-2025)
 Table 30. Global Precision Cancer Tests Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Precision Cancer Tests Revenue Market Share by Application (2026-2031)
 Table 32. North America Precision Cancer Tests Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Precision Cancer Tests Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Precision Cancer Tests Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Precision Cancer Tests Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Precision Cancer Tests Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Precision Cancer Tests Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Precision Cancer Tests Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Precision Cancer Tests Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Precision Cancer Tests Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Precision Cancer Tests Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Precision Cancer Tests Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Precision Cancer Tests Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Precision Cancer Tests Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Precision Cancer Tests Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Precision Cancer Tests Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Abbott Company Details
 Table 48. Abbott Business Overview
 Table 49. Abbott Precision Cancer Tests Product
 Table 50. Abbott Revenue in Precision Cancer Tests Business (2020-2025) & (US$ Million)
 Table 51. Abbott Recent Development
 Table 52. BD Company Details
 Table 53. BD Business Overview
 Table 54. BD Precision Cancer Tests Product
 Table 55. BD Revenue in Precision Cancer Tests Business (2020-2025) & (US$ Million)
 Table 56. BD Recent Development
 Table 57. Bio-Rad Company Details
 Table 58. Bio-Rad Business Overview
 Table 59. Bio-Rad Precision Cancer Tests Product
 Table 60. Bio-Rad Revenue in Precision Cancer Tests Business (2020-2025) & (US$ Million)
 Table 61. Bio-Rad Recent Development
 Table 62. Cynvenio Biosystems Company Details
 Table 63. Cynvenio Biosystems Business Overview
 Table 64. Cynvenio Biosystems Precision Cancer Tests Product
 Table 65. Cynvenio Biosystems Revenue in Precision Cancer Tests Business (2020-2025) & (US$ Million)
 Table 66. Cynvenio Biosystems Recent Development
 Table 67. Foundation Medicine Company Details
 Table 68. Foundation Medicine Business Overview
 Table 69. Foundation Medicine Precision Cancer Tests Product
 Table 70. Foundation Medicine Revenue in Precision Cancer Tests Business (2020-2025) & (US$ Million)
 Table 71. Foundation Medicine Recent Development
 Table 72. Genomic Health Company Details
 Table 73. Genomic Health Business Overview
 Table 74. Genomic Health Precision Cancer Tests Product
 Table 75. Genomic Health Revenue in Precision Cancer Tests Business (2020-2025) & (US$ Million)
 Table 76. Genomic Health Recent Development
 Table 77. Illumina Company Details
 Table 78. Illumina Business Overview
 Table 79. Illumina Precision Cancer Tests Product
 Table 80. Illumina Revenue in Precision Cancer Tests Business (2020-2025) & (US$ Million)
 Table 81. Illumina Recent Development
 Table 82. Myriad Genetics Company Details
 Table 83. Myriad Genetics Business Overview
 Table 84. Myriad Genetics Precision Cancer Tests Product
 Table 85. Myriad Genetics Revenue in Precision Cancer Tests Business (2020-2025) & (US$ Million)
 Table 86. Myriad Genetics Recent Development
 Table 87. NanoString Technologies Company Details
 Table 88. NanoString Technologies Business Overview
 Table 89. NanoString Technologies Precision Cancer Tests Product
 Table 90. NanoString Technologies Revenue in Precision Cancer Tests Business (2020-2025) & (US$ Million)
 Table 91. NanoString Technologies Recent Development
 Table 92. QIAGEN Company Details
 Table 93. QIAGEN Business Overview
 Table 94. QIAGEN Precision Cancer Tests Product
 Table 95. QIAGEN Revenue in Precision Cancer Tests Business (2020-2025) & (US$ Million)
 Table 96. QIAGEN Recent Development
 Table 97. Randox Laboratories Company Details
 Table 98. Randox Laboratories Business Overview
 Table 99. Randox Laboratories Precision Cancer Tests Product
 Table 100. Randox Laboratories Revenue in Precision Cancer Tests Business (2020-2025) & (US$ Million)
 Table 101. Randox Laboratories Recent Development
 Table 102. Roche Company Details
 Table 103. Roche Business Overview
 Table 104. Roche Precision Cancer Tests Product
 Table 105. Roche Revenue in Precision Cancer Tests Business (2020-2025) & (US$ Million)
 Table 106. Roche Recent Development
 Table 107. Philips Company Details
 Table 108. Philips Business Overview
 Table 109. Philips Precision Cancer Tests Product
 Table 110. Philips Revenue in Precision Cancer Tests Business (2020-2025) & (US$ Million)
 Table 111. Philips Recent Development
 Table 112. Thermo Fisher Scientific Company Details
 Table 113. Thermo Fisher Scientific Business Overview
 Table 114. Thermo Fisher Scientific Precision Cancer Tests Product
 Table 115. Thermo Fisher Scientific Revenue in Precision Cancer Tests Business (2020-2025) & (US$ Million)
 Table 116. Thermo Fisher Scientific Recent Development
 Table 117. Research Programs/Design for This Report
 Table 118. Key Data Information from Secondary Sources
 Table 119. Key Data Information from Primary Sources
 Table 120. Authors List of This Report


List of Figures
 Figure 1. Precision Cancer Tests Picture
 Figure 2. Global Precision Cancer Tests Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Precision Cancer Tests Market Share by Type: 2024 VS 2031
 Figure 4. Imaging Features
 Figure 5. In Vitro Diagnostic Features
 Figure 6. Others Features
 Figure 7. Global Precision Cancer Tests Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Precision Cancer Tests Market Share by Application: 2024 VS 2031
 Figure 9. Cancer Research Centers Case Studies
 Figure 10. Cancer Hospital Case Studies
 Figure 11. Surgical Centers Case Studies
 Figure 12. Clinics Case Studies
 Figure 13. Others Case Studies
 Figure 14. Precision Cancer Tests Report Years Considered
 Figure 15. Global Precision Cancer Tests Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Precision Cancer Tests Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Precision Cancer Tests Market Share by Region: 2024 VS 2031
 Figure 18. Global Precision Cancer Tests Market Share by Players in 2024
 Figure 19. Global Top Precision Cancer Tests Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Tests as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Precision Cancer Tests Revenue in 2024
 Figure 21. North America Precision Cancer Tests Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Precision Cancer Tests Market Share by Country (2020-2031)
 Figure 23. United States Precision Cancer Tests Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Precision Cancer Tests Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Precision Cancer Tests Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Precision Cancer Tests Market Share by Country (2020-2031)
 Figure 27. Germany Precision Cancer Tests Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Precision Cancer Tests Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Precision Cancer Tests Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Precision Cancer Tests Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Precision Cancer Tests Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Precision Cancer Tests Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Precision Cancer Tests Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Precision Cancer Tests Market Share by Region (2020-2031)
 Figure 35. China Precision Cancer Tests Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Precision Cancer Tests Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Precision Cancer Tests Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Precision Cancer Tests Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Precision Cancer Tests Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Precision Cancer Tests Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Precision Cancer Tests Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Precision Cancer Tests Market Share by Country (2020-2031)
 Figure 43. Mexico Precision Cancer Tests Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Precision Cancer Tests Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Precision Cancer Tests Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Precision Cancer Tests Market Share by Country (2020-2031)
 Figure 47. Turkey Precision Cancer Tests Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Precision Cancer Tests Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Precision Cancer Tests Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Abbott Revenue Growth Rate in Precision Cancer Tests Business (2020-2025)
 Figure 51. BD Revenue Growth Rate in Precision Cancer Tests Business (2020-2025)
 Figure 52. Bio-Rad Revenue Growth Rate in Precision Cancer Tests Business (2020-2025)
 Figure 53. Cynvenio Biosystems Revenue Growth Rate in Precision Cancer Tests Business (2020-2025)
 Figure 54. Foundation Medicine Revenue Growth Rate in Precision Cancer Tests Business (2020-2025)
 Figure 55. Genomic Health Revenue Growth Rate in Precision Cancer Tests Business (2020-2025)
 Figure 56. Illumina Revenue Growth Rate in Precision Cancer Tests Business (2020-2025)
 Figure 57. Myriad Genetics Revenue Growth Rate in Precision Cancer Tests Business (2020-2025)
 Figure 58. NanoString Technologies Revenue Growth Rate in Precision Cancer Tests Business (2020-2025)
 Figure 59. QIAGEN Revenue Growth Rate in Precision Cancer Tests Business (2020-2025)
 Figure 60. Randox Laboratories Revenue Growth Rate in Precision Cancer Tests Business (2020-2025)
 Figure 61. Roche Revenue Growth Rate in Precision Cancer Tests Business (2020-2025)
 Figure 62. Philips Revenue Growth Rate in Precision Cancer Tests Business (2020-2025)
 Figure 63. Thermo Fisher Scientific Revenue Growth Rate in Precision Cancer Tests Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Precision Cancer Diagnostic Tests Market
Precision Cancer Imaging Market
Global Precision Cancer Medicine Market Research Report 2024
In Vitro Colorectal Cancer Screening Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hematology Oncology Diagnostics Market Research Report 2024
Global Tumor Marker Testing Market Research Report 2024
Global Personalized Precision Medicine Market Research Report 2024
Global Tumor NGS Genetic Testing Market Research Report 2024
Precision Medicine Diagnostics Market
Global Noninvasive Cancer Diagnostics and Technology Market Research Report 2025
Global Genomic Testing in Cancer Market Research Report 2024
In vitro Diagnostic Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rapid Cancer Tests Market Insights Forecast to 2030
In Vitro Colorectal Cancer Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cancer Oncology Testing Market Research Report 2024
Global Cancer Test Kit Market Insights Forecast to 2030
Global Cancer Genomic Testing Market Research Report 2024
Global Breast Cancer Diagnostic and Drug Technologies Market Insights Forecast to 2030
Global Breast Cancer Diagnostic Technologies Market Insights Forecast to 2030
Global Oncology Clinical Trial Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions